Taiwan Medical Device Registration

Unlock the Taiwanese market with expert regulatory guidance, quality system oversight, and an independent Taiwan agent, with Cisema.

We help foreign manufacturers of Taiwan medical devices and IVDs in Taiwan successfully register their products with the Taiwan Food and Drug Administration (TFDA), meet all documentation and quality system documentation requirements, and maintain compliance across the device lifecycle. As your Taiwan Registration Holder (TRH), we manage your Taiwan medical device registration process from initial classification strategy through post-market surveillance.

With a presence in Taipei and a deep understanding of Taiwan’s Medical Devices Act, Cisema acts as your trusted in country regulatory representative. We provide complete support for device classification, technical reviews, quality system documentation QSD, and registration submission for Class I, Class II, and III devices.

Whether registering a new product, seeking amendments to your medical device permit license, or managing post-market obligations, Cisema gives you clarity, speed, and control.

From risk assessment and QMS alignment to TFDA application support and labeling compliance, we simplify your path to market. We also assist with documentation aligned to the Good Manufacturing Practice requirements and ISO 13485, ensuring conformity with Taiwan medical device expectations.

Taiwan Medical Device Registration
Medical Device Registration in Taiwan

Service for IVD & Medical Device Registration in Taiwan

Cisema’s team manages your full device registration in Taiwan, aligning with the Taiwan Food and Drug Administration authority’s requirements and supporting a seamless market entry.

Regulatory Strategy & Classification

Classify your Taiwan medical device or IVD under Taiwan’s risk-based framework (Class I, Class II, or Class III)
Determine whether fast-track or pre market approval based on reference countries is applicable
Define the most effective regulatory pathway according to your primary intended actions

Quality System Documentation (QSD) Registration

Before submitting your product registration application to TFDA, most manufacturers must obtain a Quality System Documentation (QSD) certificate. This mandatory step verifies your compliance with ISO 13485 or an equivalent quality management system. We guide you in preparing and submitting your full QSD application and managing all interactions with TFDA until your certificate is issued.

QSD is required for all Class II and III devices, and many Class I products
Some Class I non-sterile, non-measuring devices may be exempt
QSD approval is performed as a remote, paper-based review by the Taiwan Food and Drug authority
Documentation includes ISO 13485 certificate, SOPs, quality manual and facility details
QSD and product registration can be submitted in parallel, but TFDA will issue the medical device permit license only after QSD approval
Typical QSD review time is around 6 months and the certificate is valid for 3 years.

Registration Application & TFDA Submission

Submit through the TFDA e-Portal and manage all administrative and technical reviews
Act as your regulatory contact for communication with the TFDA
Localize Instructions for Use (IFU), packaging, and labeling to meet Taiwan Food and Drug Administration standards
Coordinate submission fees and respond to authority feedback throughout the pre market approval process.

Post-Approval Services

Handle renewals, reclassification, and amendments to the medical device permit license
Manage adverse event reporting, serious adverse event follow-up, and Field Safety Corrective Actions (FSCA) coordination.

Taiwan Agent & Taiwan Registration Holder Services

Foreign manufacturers must appoint a Taiwan agent or in country regulatory representative as the legal license holder to register with the Taiwan Food and Drug Administration. Cisema acts as your compliant TRH, fulfilling all regulatory duties transparently.

What we do:

Serve as your legal license holder for all Taiwan medical device, IVD and combined product registrations
Submit and maintain your product license with TFDA
Issue Letters of Authorization to your preferred importers and distributors
Enable flexibility in changing distributors without re-registration
Monitor post-market updates and ensure ensuring compliance with the Medical Devices Act
Manage direct prevention actions like FSCA and recalls
Maintain your quality system, and support audits and inspections tied to ISO 13485

Quality Control Inspection Services in Taiwan

Cisema also provides tailored inspection services for Taiwan medical devices and IVDs to ensure compliance with local and international standards.

Incoming Goods Inspections

Verify packaging, labeling, and shipping conditions upon arrival
Review documentation including invoices, certifications, and declarations of conformity
Confirm product readiness for the Taiwanese market

In-Process Quality Monitoring

Inspect during repackaging or relabeling for hygiene, SOPs, and quality system control
Validate traceability and batch consistency

Final Product Release Inspections

Conduct AQL sampling and performance checks
Ensure conformity of labeling and IFU with Taiwanese regulatory requirements

Special Inspection Projects

Support Good Manufacturing Practice audits and TFDA site inspections
Collaborate with third-party bodies for tailored compliance audits
Conduct serial number validation and corrective action reviews.

Why Work with Cisema?

Local expertise with global reach

Our bilingual teams bridge international quality standards with local regulations

Proven track record

Over 20 years supporting market approvals and compliance in China and Asia Pacific

End-to-end solutions

From system setup to post-market surveillance, we ensure quality management and regulatory compliance throughout the product lifecycle

Industry breadth

Cross-sector expertise in life sciences, food, veterinary, consumer and industrial goods

Role of a China Agent

Useful Articles

View More

Understanding Local Testing for Medical Devices & IVDs in Indonesia: Requirements & Registration Guide

Learn when local testing is required for medical devices and IVDs in Indonesia, which products are affected, and how testing impacts registration requirements.

August 31, 2026
Understanding Local Testing for Medical Devices & IVDs in Indonesia: Requirements & Registration Guide
An Indonesian male medical professional in profile, wearing dark blue scrubs, a blue surgical cap, safety glasses, a white mask, and a blue-tubed stethoscope, presses a button on a dual-monitor medical control panel in a clinical operating setting.

China Medical Device GMP vs ISO 13485: Key Differences Explained

Understand the key differences between China Medical Device GMP and ISO 13485, including requirements for quality management, suppliers, facilities and documentation.

August 26, 2026
China Medical Device GMP vs ISO 13485: Key Differences Explained
Two Chinese medical device technicians, a woman and a man wearing white lab coats, surgical caps, face masks, and protective gloves, stand side by side in a sterile cleanroom environment.

5-Step Guide to Taiwan Medical Device Classification (TFDA)

How to determine medical device classification in Taiwan: the TFDA catalogue, the 16 categories, Class I-III risk levels, and what to do when no item matches.

August 21, 2026
5-Step Guide to Taiwan Medical Device Classification (TFDA)

Guide to Indonesia Medical Device Post-Registration Changes: Notification, Variation, or New Registration

Learn when medical device and IVD changes in Indonesia require a notification, variation, or new registration, and how to maintain ongoing regulatory compliance.

August 5, 2026
Guide to Indonesia Medical Device Post-Registration Changes: Notification, Variation, or New Registration

How Vietnam Medical Device Registration Works (Timelines, Fees, & AR Strategy)

Gain an overview of the medical device registration process in Vietnam with timelines, fees, and Authorized Representative requirements.

August 4, 2026
How Vietnam Medical Device Registration Works (Timelines, Fees, & AR Strategy)

Understanding the ASEAN Medical Device Market: Comparing 6 Strategic Markets

Explore the medical device market opportunities, regulations, and registration pathways across Malaysia, Singapore, Vietnam, and other key ASEAN countries.

August 4, 2026
Understanding the ASEAN Medical Device Market: Comparing 6 Strategic Markets
Previous
Previous

Other Markets We Support for Medical Device & IVD Registration

In addition to Taiwan, Cisema supports IVD and device registration, regulatory representation, and quality inspection services in:

China

Hong Kong SAR

Singapore

Malaysia

Vietnam

Philippines

Indonesia

Thailand

South Korea

Latest Insights

View More

Malaysia NPRA Updates Cosmetic Ingredient Requirements Under the ASEAN Cosmetic Directive

Circular No. 2/2026 revises prohibited, restricted, colorant, and preservative requirements for cosmetics marketed in Malaysia.

August 20, 2026
Malaysia NPRA Updates Cosmetic Ingredient Requirements Under the ASEAN Cosmetic Directive

China Overhauls Cosmetic Safety Rules with GB 7916-2026: Is Your Brand Ready?

Brands must audit ingredients, suppliers and packaging before January 2028 to ensure compliance with GB 7916-2026.

August 18, 2026
China Overhauls Cosmetic Safety Rules with GB 7916-2026: Is Your Brand Ready?
Scientist in clean modern room inspects cosmetics.

China Expands Animal Testing Data Exemptions in Major Cosmetics Registration and Filing Reform

Companies can benefit from expanded toxicology data exemptions, simplified cosmetics registration procedures, and more efficient compliance pathways

August 18, 2026
China Expands Animal Testing Data Exemptions in Major Cosmetics Registration and Filing Reform

Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites

As of July 1, 2026, Taiwan has completed its cosmetic GMP rollout, extending mandatory ISO 22716-based manufacturing standards to nearly all cosmetic factories

August 18, 2026
Taiwan Extends Cosmetic GMP Requirements to Nearly All Manufacturing Sites

China Updates New Cosmetic Ingredient Registration Rules: Several Higher-Risk Ingredient Categories Removed

New NCI rules reduce administrative burden, streamline dossiers, and expand opportunities to reuse existing safety data.

August 18, 2026
China Updates New Cosmetic Ingredient Registration Rules: Several Higher-Risk Ingredient Categories Removed
This stock photo features a close-up, high-angle shot focusing on a skincare product arrangement set against a light-colored, wood-grain surface.

NMPA Opens Consultation on Two Draft Cosmetic Adverse Reaction Standards: Cosmetic Cheilitis & Cosmetic Contact Urticaria

Review China's new draft standards for cosmetic cheilitis and contact urticaria before the August 15, 2026, consultation deadline.

August 18, 2026
NMPA Opens Consultation on Two Draft Cosmetic Adverse Reaction Standards: Cosmetic Cheilitis & Cosmetic Contact Urticaria
Previous
Previous

Get in Touch with Our Medical Devices Team

And discover how we can support you in achieving approval for your medical device in Taiwan.

Request Proposal